Measurement of safety range in primary nasal transsphenoidal approach for pituitary surgery.

J Craniofac Surg

Department of Anatomy, Norman Bethune Medical School, Jilin University, Changchun, Jilin Province, People's Republic of China.

Published: March 2013

Although primary nasal transsphenoidal approach of pituitary surgery is widely used, no previous reports have determined the safety range of the surgery. The aim of our study was to clarify the medical reference range of safety angles and distances. One hundred forty-four (49 males, 95 females) participated in this study anonymously. We measured 4 parameters to achieve our goals, and the results are as follows: Angle 1 was 11.08 degrees for men and 11.31 degrees for women. Distance 1 was 17.22 mm for men and 16.46 mm for women. Angle 2 was 9.03 degrees for women and 8.73 degrees for men. Distance 2 was 14.54 mm for men and 14.10 mm for women. Angle 1 was 8.57 degrees for young, 8.93 degrees for adult, and 9.24 degrees for old. Distance 1 was 13.73 mm for young, 14.47 mm for adult, and 14.43 mm for old. Angle 2 was 11.24 degrees for young, 11.33 degrees for adult, and 11.10 degrees for old. Distance 2 was 16.86 mm for young, 16.90 mm for adult, and 16.39 mm for old. The differences in all 4 parameters were not statistically significant in comparison of sex and ages (P > 0.01). Hence, the 4 parameters that we determined contribute to the safety of the primary nasal transsphenoidal approach in pituitary surgery.

Download full-text PDF

Source
http://dx.doi.org/10.1097/SCS.0b013e31827c7cb9DOI Listing

Publication Analysis

Top Keywords

primary nasal
12
nasal transsphenoidal
12
transsphenoidal approach
12
approach pituitary
12
pituitary surgery
12
degrees
10
safety range
8
degrees men
8
degrees women
8
women angle
8

Similar Publications

Introduction: High-Flow Nasal Therapy (HFNT) is an innovative non-invasive form of respiratory support. Compared to standard oxygen therapy (SOT), there is an equipoise regarding the effect of HFNT on patient-centred outcomes among those at high risk of developing postoperative pulmonary complications after undergoing cardiac surgery. The NOTACS trial aims to determine the clinical and cost-effectiveness of HFNT compared to SOT within 90 days of surgery in the United Kingdom, Australia, and New Zealand.

View Article and Find Full Text PDF

Introduction: Sedation practices for colonoscopy indeed vary widely around the globe. Due to a lack of data on intravenous paracetamol, we aimed to investigate the clinical efficacy of intravenous paracetamol compared to intravenous fentanyl under propofol deep sedation for colonoscopy.

Methods: A total of 225 patients who underwent colonoscopy at Siriraj Hospital were randomly assigned to two groups.

View Article and Find Full Text PDF

Background: To compare structural and vascular parameters between advanced pseudoexfoliation glaucoma (PXG) and primary open-angle glaucoma (POAG).

Methods: One hundred and six eyes of 81 patients were enrolled in this cross-sectional study. All patients underwent complete ophthalmic examination and measurement of the thickness of the peripapillary retinal nerve fiber layer (RNFL) and ganglion cell complex (GCC).

View Article and Find Full Text PDF

Acute rhinosinusitis (ARS) in children may be accompanied by acute otitis media (AOM) which is often associated with bacterial co-infections. These conditions are among the primary reasons that children visit hospitals and require antibiotic treatment. This study evaluated the efficacy of the nasal-spraying probiotics (LiveSpo Navax containing 5 billion Bacillus subtilis and B.

View Article and Find Full Text PDF

Effects of Elexacaftor-Tezacaftor-Ivacaftor on Nasal and Sinus Symptoms in Children With Cystic Fibrosis.

Pediatr Pulmonol

January 2025

Hôpital Femme Mère Enfant, Hospices Civils de Lyon, 59 Boulevard Pinel, Lyon, France.

Background: New CFTR Modulator triple therapy Elexacaftor-Ivacaftor-Tezacaftor (ETI) prove efficacy in pulmonary outcomes. However, its impact on nasal sinus symptoms in children has not been specifically studied. The aim of this study is to evaluate the impact of this therapy on nasal sinus symptomatology in children aged 6-12 years.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!